Exploring the Ethical Implications of AI Use in Clinical Trials Virtual Roundtable
10 December 2024 | Online
4pm-5pm GMT/ 5pm-6pm CET / 11am-12pm EST
The use of artificial intelligence in clinical trials holds immense promise, from accelerating drug discovery to optimizing patient recruitment and trial design. However, the integration of AI also introduces complex ethical considerations that must be carefully navigated.
This virtual roundtable discussion will explore the ethical implications of AI use in clinical trials, paying attention to emerging risks, key considerations, and future trends.
Learn From Our Panel of Clinical Trials Experts
Emily Donohoe
Portfolio Director - Clinical Trials
AMG World
Nikita Sharma
Digital Health Solutions Manager
Astellas Pharma
This session will provide you with the necessary tools to:
- Outline key steps to mitigate algorithmic bias and avoid AI discrimination against patient populations in clinical trial enrolment and outcome assessment.
- Define clear boundaries for human oversight in AI-powered clinical trials, with structured frameworks for clinician and researcher involvement in critical decision-making.
- Implement robust security measures to safeguard patient confidentiality and data integrity when leveraging AI systems for health information analysis.
- Identify ethical frameworks and guidelines to govern the use of AI in clinical trials and ensure effective implementation.
- Engaged various stakeholders, including patients, clinicians, researchers, ethicists, and AI experts in the development and deployment of AI in clinical trials.
- Define future processes for continuous monitoring of AI performance, safety, and ethics in clinical trials.
Who you will meet:
VPs, Directors, Global Heads of
- AI/ML/Clinical AI
- Data/Data Science/Analytics
- Statistics/Statistical Analysis/Quantitative Science
- Innovation
- Clinical Trials/Clinical Research/ Clinical Development
- Clinical Monitoring/ Clinical Operations
- Patient recruitment & Retention
